Longeveron Inc. (LGVN) Amount of Cash per Share

Symbol and logo of brand Longeveron Corporation (LGVN)

Longeveron Inc. (LGVN) experienced management focuses on R&D transparency and strict compliance, which is supported by the cash per share calculation. The value of 2.15 determines the latest liquidity valuation metric. Business resilience relies on the seamless operation of the bio-complex, although success depends on clinical trial outcomes and the purity of patents for treating age-related pathologies.

LGVN Longeveron Corporation: Cash Funds per Share in the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Longeveron Inc (LGVN)

- market price and analyst price targets:
- cash and cash flow data:
Comprehensive company analysis:Longeveron Corp LGVN
Flagship merchandise of Longeveron

Longeveron Inc. (LGVN) is actively developing regenerative stem cell therapy to combat age-related pathologies. An analysis of cash per share allows for an assessment of the issuer's liquid reserve on a per-share basis. This indicator reflects the actual volume of capital available to fund clinical trials. While a high metric reduces the probability of default, excessive cash may indicate inefficient resource management. It is critical for investors to weigh this margin of safety against the company's growth rates.